Prof. Ravindra K. Rawal
Prof. Ravindra K. Rawal
CSIR-North East Institute of Science and Technology, Jorhat, India
Verified email at
Cited by
Cited by
Chemometrics tools used in analytical chemistry: An overview
N Kumar, A Bansal, GS Sarma, RK Rawal
Talanta 123, 186-199, 2014
2-(Aryl)-3-furan-2-ylmethyl-thiazolidin-4-ones as selective HIV-RT inhibitors
RK Rawal, YS Prabhakar, SB Katti, E De Clercq
Bioorganic & medicinal chemistry 13 (24), 6771-6776, 2005
Role of sulphur-heterocycles in medicinal chemistry: An update
S Pathania, RK Narang, RK Rawal
European journal of medicinal chemistry 180, 486-508, 2019
Design, synthesis, and evaluation of 2-aryl-3-heteroaryl-1, 3-thiazolidin-4-ones as anti-HIV agents
RK Rawal, R Tripathi, SB Katti, C Pannecouque, E De Clercq
Bioorganic & medicinal chemistry 15 (4), 1725-1731, 2007
Recent synthetic and medicinal perspectives of dihydropyrimidinones: A review
R Kaur, S Chaudhary, K Kumar, MK Gupta, RK Rawal
European Journal of Medicinal Chemistry 132, 108-134, 2017
Synthetic and Medicinal Perspective of Thiazolidinones: A Review
SK Manjal, R Kaur, R Bhatia, K Kumar, V Singh, R Shankar, R Kaur, ...
Bioorganic Chemistry 75, 406-423, 2017
Chemometrics: A new scenario in herbal drug standardization
A Bansal, V Chhabra, RK Rawal, S Sharma
Journal of Pharmaceutical Analysis 4 (4), 223-233, 2014
Synthesis and evaluation of 2-(2, 6-dihalophenyl)-3-pyrimidinyl-1, 3-thiazolidin-4-one analogues as anti-HIV-1 agents
RK Rawal, R Tripathi, SB Katti, C Pannecouque, E De Clercq
Bioorganic & medicinal chemistry 15 (9), 3134-3142, 2007
Design and synthesis of 2-(2, 6-dibromophenyl)-3-heteroaryl-1, 3-thiazolidin-4-ones as anti-HIV agents
RK Rawal, R Tripathi, SB Katti, C Pannecouque, E De Clercq
European journal of medicinal chemistry 43 (12), 2800-2806, 2008
Recent advances in the chemistry and biology of benzothiazoles
RK Gill, RK Rawal, J Bariwal
Archiv der Pharmazie 348 (3), 155-178, 2015
Diversity-oriented synthesis of fused-imidazole derivatives via Groebke–Blackburn–Bienayme reaction: a review
N Devi, RK Rawal, V Singh
Tetrahedron 71 (2), 183-232, 2015
Recent synthetic and medicinal perspectives of tryptanthrin
R Kaur, SK Manjal, RK Rawal, K Kumar
Bioorganic & medicinal chemistry 25 (17), 4533-4552, 2017
CP‐MLR/PLS Directed Structure‐Activity Modeling of the HIV‐1 RT Inhibitory Activity of 2, 3‐Diaryl‐1, 3‐thiazolidin‐4‐ones
YS Prabhakar, VR Solomon, RK Rawal, MK Gupta, SB Katti
QSAR & Combinatorial Science 23 (4), 234-244, 2004
Medicinal attributes of imidazo [1, 2-a] pyridine derivatives: an update
N Devi, D Singh, R K Rawal, J Bariwal, V Singh
Current topics in medicinal chemistry 16 (26), 2963-2994, 2016
Drug metabolizing enzymes and their inhibitors' role in cancer resistance
S Pathania, R Bhatia, A Baldi, R Singh, RK Rawal
Biomedicine & Pharmacotherapy 105, 53-65, 2018
Polysaccharides based nanomaterials for targeted anti-cancer drug delivery
D Dheer, D Arora, S Jaglan, RK Rawal, R Shankar
Journal of drug targeting 25 (1), 1-16, 2017
The critical role of bisphosphonates to target bone cancer metastasis: an overview
T Singh, V Kaur, M Kumar, P Kaur, RSR Murthy, RK Rawal
Journal of Drug Targeting 23 (1), 1-15, 2015
An expeditious synthesis of thiazolidinones and tetathiazanones
RK Rawal, T Srivastava, W Haq, SB Katti
Journal of Chemical Research 2004 (5), 368-369, 2004
Non-nucleoside inhibitors of the hepatitis C virus NS5B RNA-dependant RNA polymerase: 2-aryl-3-heteroaryl-1, 3-thiazolidin-4-one derivatives
RK Rawal, SB Katti, N Kaushik-Basu, P Arora, Z Pan
Bioorganic & medicinal chemistry letters 18 (23), 6110-6114, 2008
Modified H5 promoter improves stability of insert genes while maintaining immunogenicity during extended passage of genetically engineered MVA vaccines
Z Wang, J Martinez, W Zhou, C La Rosa, T Srivastava, A Dasgupta, ...
Vaccine 28 (6), 1547-1557, 2010
The system can't perform the operation now. Try again later.
Articles 1–20